![](/img/cover-not-exists.png)
Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR–ABL chronic myeloid leukemia
Stephen E. Langabeer, Mireille Crampe, Karl Haslam, Johanna Kelly, Mary R. CahillVolume:
34
Year:
2010
Language:
english
Pages:
1
DOI:
10.1016/j.leukres.2010.01.025
File:
PDF, 143 KB
english, 2010